Kubota Pharmaceutical Holdings Company is Pharmaceuticals in Japan that focus on Holdings Co Ltd business. Founded in 2015. They cover business area such as Kubota Pharmaceutical Holdings Co Ltd, portfolio, drug, device, million, people, therapeutic, operation, incidental or relate thereto, its pipeline product, VCM-Emixustat HCI, Lanosterol, Optogenetics.
2015
( 9 years old in 2024 )
Holdings Co Ltd
-
Level 18 Yebisu Garden Place Tower
4-20-3 Ebisu Shibuya-ku
Tokyo
Japan
Private
Kubota Pharmaceutical Holdings Co Ltdportfoliodrugdevicemillionpeopletherapeuticoperationincidental or relate theretoits pipeline productVCM-Emixustat HCILanosterolOptogenetics
* We use standard office opening hours in near Kubota Pharmaceutical Holdings Company's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Kubota Pharmaceutical Holdings Company is Pharmaceuticals business from Japan that founded in 2015 (9 years old in 2024), Kubota Pharmaceutical Holdings Company business is focusing on Holdings Co Ltd.
Kubota Pharmaceutical Holdings Company headquarter office and corporate office address is located in Level 18 Yebisu Garden Place Tower 4-20-3 Ebisu Shibuya-ku Tokyo Japan.
Kubota Pharmaceutical Holdings Company was founded in Japan.
In 2024, Kubota Pharmaceutical Holdings Company is currently focus on Holdings Co Ltd sector.
Above is snippet of Google Trends for "Holdings Co Ltd" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Kubota Pharmaceutical Holdings Company, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
